BMRA
BIOMERICA INC
NASDAQ · Healthcare · Medical - Devices · US
$1.76
−4.86%Year over year
Reported trailing growth
- Revenue
- -11.2%
- EBITDA
- -48.8%
- EBIT
- -11.2%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +103.4%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.9%
- EBITDA
- -7.2%
- EBIT
- -3.6%
- Net income
- +24.1%
- EPS
- +39.8%
- Free cash flow
- +11.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Aug 1, 2026